A Phase 2 Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab forPreviously Untreated Subjects With Intermediate- to Very High-Risk MyelodysplasticSyndromes (MDS)

Project: Research project

Project Details

Description

A Phase 2 Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab for Previously Untreated Subjects With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
StatusActive
Effective start/end date6/21/23 → 3/31/28

Funding

  • ASTEX PHARMACEUTICALS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint